$NSPR

Number of shareholders of InspireMD Inc. – GETTEX:II2

This article provides only the title for information about the number of shareholders of InspireMD Inc. (II2) on GETTEX. The content is primarily navigation and boilerplate text from TradingView, with no specific shareholder data presented in the accessible text.

Original reporting
Published May 7, 2026, 4:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 7, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Number of shareholders of InspireMD Inc. – GETTEX:II2 — source image
Decision brief

The 30-second read

$NSPRNeutralLow
01

Why it matters

Due to the absence of detailed shareholder data or recent corporate developments, the impact on trading activity or stock valuation is expected to be minimal.

02

Market read

The news has limited relevance for traders and investors, given its superficial content and lack of actionable data.

03

What to watch

Potential undisclosed shareholder changes or corporate actions not covered in this brief, which could be relevant if further information becomes available.

Timing: low

Background

The article is a navigational page from TradingView providing only the title related to the number of shareholders of InspireMD Inc. (II2).

Company-level read

Ticker impact

$NSPRNeutralLow confidence
Context

Low relevance due to minimal impact on InspireMD Inc. (II2) or related markets.

Expected impact

No significant price movement anticipated in the short to medium term.

Evidence & confidence

The source offers minimal actionable information, and the relevance score is low (0.0085), indicating limited influence on trading decisions.

Market effects

Limited sector impact due to lack of new information affecting industry fundamentals.

No regional market implications expected.

Minimal global relevance given the specificity and limited data.

Counterpoint

Some traders might interpret the lack of shareholder data as a potential area for future interest, but current evidence does not support this.

Key entities

  • InspireMD Inc.

    A medical device company focused on innovative solutions.

Related articles

$NSPRMed

InspireMD, Inc. (NSPR): Results of Operations and Financial Condition

InspireMD, Inc. (NSPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 InspireMD Reports Second Quarter 2026 Financial Results - Company to host investor conference call today, August 17 th , at 8:30am EDT - Miami, FL — August 17, 2026 – InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), develope

$NSPRMedAI 8/10

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures

InspireMD (Nasdaq: NSPR) reported 30-day results from its CGUARDIANS II trial of the CGuard Prime 80 cm implant for TCAR. In 50 high-risk patients, acute device success was 100% (50/50) with no deaths, strokes, MI, or stent thrombosis at 30 days. The company said an FDA PMA supplement is under review, with potential approval in H2 2026.

$RKLBMed

Rocket Lab launches eight Globalstar satellites

Rocket Lab (NASDAQ:RKLB) launched eight Globalstar satellite platforms on 15 August from Cape Canaveral, the first batch under a $143 million contract with MDA Space (TSX:MDA). Rocket Lab said it established contact and confirmed normal power and operations. The 500 kg spacecraft will be commissioned before joining Globalstar’s direct-to-device network.